FORENSIC TOXICOLOGY - Bio Medical Forensics
FORENSIC TOXICOLOGY - Bio Medical Forensics
FORENSIC TOXICOLOGY - Bio Medical Forensics
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Celebrating<br />
60 years<br />
K1 Gas Chromatography of Postmortem<br />
Blood Revealing Sevoflurane in a<br />
Patient Six Hours Post-Op<br />
Diane C. Peterson, MD*, and Susan Kloda, MT, University of Alabama at<br />
Birmingham, Department of Pathology, 619 South 19th Street,<br />
Birmingham, AL 35233; Gary T. Simmons, MD, and Robert M. Brissie,<br />
MD, Jefferson County <strong>Medical</strong> Examiner’s Office, 1515 South 6th Avenue,<br />
Birmingham, AL 35233; and C. Andrew Robinson, PhD, University of<br />
Alabama, Department of Pathology, 619 South 19th Street, Birmingham,<br />
AL 35233<br />
Attendees will understand basic physiology and properties of sevoflurane,<br />
a general anesthetic used in same-day surgeries. Attendees will also<br />
learn that sevoflurane may interfere with an ethanol peak with a certain<br />
method of gas chromatography.<br />
This poster will impact the forensic science community by alerting the<br />
community to the possibility of the presence of “ethanol” peaks on gas<br />
chromatography due to sevoflurane in post-operative patients.<br />
A 54-year-old female patient underwent facelift surgery which lasted<br />
approximately six hours. During surgery, sevoflurane was used for induction<br />
and maintenance of anesthesia. There were no intraoperative complications.<br />
The patient was discharged home about one hour and forty-five minutes postop<br />
at 1645 hours. Her only post-op complaint was of a migraine headache,<br />
which was treated with topiramate (Topamax®). Patient history as detailed<br />
by her family, stated that the patient consumed only ginger ale and yogurt<br />
prior to going to sleep after surgery. At 2100 hours, she was sleeping soundly.<br />
At 2115 hours, she was not breathing and unresponsive. Postmortem examination<br />
revealed focal moderate calcific atherosclerotic narrowing of the<br />
proximal left anterior descending coronary artery, microscopic fibrosis of<br />
the superior interventricular septum of the heart near the atrioventricular<br />
node, and mild to moderate microvesicular steatosis of the liver. Postmortem<br />
toxicology revealed the presence of citalopram (Celexa®), lidocaine, morphine,<br />
and fentanyl. Gas chromatography (GC) of postmortem blood revealed<br />
a peak at 2.496 seconds retention time, consistent with ethanol<br />
(retention time 2.3 ± 0.1 sec). The concentration of ethanol was calculated<br />
to be 0.05 g/dL. Antemortem blood also revealed ethanol by GC at a<br />
concentration of 0.04 g/dL. However, the vitreous fluid was negative for<br />
ethanol.<br />
Due to the family’s insistence that the patient had not consumed ethanol,<br />
possible interferences were sought. Of the medications the patient received,<br />
sevoflurane was the best possible medication to cause interference. Sevoflurane<br />
[fluoromethyl 2,2,2,-trifluoro-1-(trifluoromethyl) ethyl ether] is a four<br />
carbon molecule that exists as a liquid and is used for induction and maintenance<br />
of anesthesia. A review of the literature revealed two manuscripts<br />
which reported ethanol and sevoflurane peaks to be within 0.1 and 0.15<br />
seconds of each other (<strong>Bio</strong>med Chromatogr 2004; 18: 714-18 and Clin<br />
Chem 2001; 47: 281-91, respectively). Ethanol-negative blood was spiked<br />
with varying dilutions of sevoflurane, which co-eluted with ethanol. For<br />
example, the retention time of the 1:20,000 dilution was 2.483 seconds.<br />
Volatile analysis was performed with a head space procedure, using<br />
n-propanol as the internal standard. The column was a 6 foot Porapak-S at<br />
a temperature of 180°C. Instrumentation was Shimadzu GC-I 4A, Kyoto,<br />
Japan. Due to the high volatility of sevoflurane, a linear concentration curve<br />
could not be produced.<br />
A study by Kharasch et al. of sevoflurane’s metabolism and pharmacokinetics<br />
shows that it can still be detected in a patient’s blood several hours<br />
after an administration of three to five hours (Anesthesiology 1995; 82:<br />
1369-78). The average half-life of sevoflurane in that study was 2.8 ± 1.0<br />
hours. The above patient died approximately six hours after the end of<br />
<strong>TOXICOLOGY</strong><br />
1948 ~ 2008<br />
anesthetic administration. The long detection time may be partially due to<br />
the high partition coefficient for adipose tissue. Adipose tissue dominates the<br />
pharmacokinetics past three hours post-administration (BMC Clin Pharmacol<br />
2007; 7:1-21). The above patient had a body mass index of 28.6 kg/m2 ,<br />
indicating a possible increase in body fat percentage over normal.<br />
Therefore, although ethanol cannot be completely excluded, it is likely<br />
that the above patient did have sevoflurane in her blood, causing an interfering<br />
peak on gas chromatography. An interfering peak was obtained when<br />
ethanol-negative blood was spiked with sevoflurane. However, due to the<br />
high volatility of sevoflurane, consistent data points could not be obtained to<br />
determine the concentration of sevoflurane in the patient’s blood.<br />
Gas Chromatography, Sevoflurane, Ethanol<br />
K2 Signature Analysis of 25 Illicit Cocaine<br />
Samples and a Comparison to Analysis<br />
by AccuTOF DART<br />
Jeri D. Ropero-Miller, PhD*, Peter R. Stout, PhD, Edward J. Minden<br />
Jr., BS, and Nichole D. Bynum, MS, RTI International, Center for Forensic<br />
Sciences, 3040 Cornwallis Road, Building 3, Research Triangle Park, NC<br />
27709; John F. Casale, BS, Drug Enforcement Administration, Special<br />
Testing Laboratory, 22624 Dulles Summit Court, Dulles, VA 20166;<br />
Insook Kim, PhD, Jennifer Runkle, BS, Marilyn Past, PhD, and Buddha D.<br />
Paul, PhD, Armed Forces Institute of Pathology, 1413 Research<br />
Boulevard, Building 102, Rockville, MD 20850<br />
After attending this presentation, attendees will gain an enhanced<br />
understanding of multiple techniques for characterization of illicit cocaine<br />
and their ability to assess purity, level of performance, and their ability to<br />
determine specific compounds of interest.<br />
This presentation will impact the forensic science community by<br />
providing a comparison of established quantitative, chromatographic method<br />
to a novel qualitative time-of flight mass spectrometric method to determine<br />
the purity of illicit cocaine and its relative abundance of signature<br />
compounds.<br />
Introduction: Characterization of 25 illicit cocaine samples was<br />
undertaken in support of a research project funded in part by the National<br />
Institute of Justice (NIJ Award # 2006-DN-BX-K019) examining the ratios<br />
of cocaine-related compounds in hair samples contaminated with cocaine.<br />
Various coca-related compounds, isotope ratios and solvent determinations<br />
among other parameters are used to determine the manufacturing process<br />
and geographical origin of cocaine exhibits. Furthermore, this information<br />
is a useful tool to answer questions related to cocaine distribution and<br />
trafficking.<br />
A novel application of direct analysis in real time (DART) sample<br />
introduction coupled with time-of-flight (TOF) mass spectrometry was<br />
evaluated for analyzing 25 samples of bulk powdered illicit cocaine hydrochloride<br />
salt seized by the Drug Enforcement Administration (DEA). The<br />
cocaine samples were analyzed by the DEA to determine their “signature”<br />
including their purity and the presence of specific compounds including<br />
products of manufacture, adulterants, and other cocaine analytes including<br />
oxidation products. The results of the analysis were then compared to data<br />
obtained by CFS to assess the AccuTOF-DART’s level of performance.<br />
Methods: Analysis was conducted in positive mode using AccuTOF-<br />
DART mass spectrometry. After analysis of the cocaine samples, each data<br />
set was examined for the presence of cocaine analytes (e.g., cocaine,<br />
benzoylecgonine, ecgonine ethyl ester, cocaethylene, norcocaine,<br />
anhydroecgonine methyl ester, truxillines, other ethyl esters) and a number<br />
87 * Presenting Author